Palestinian (Al-Quds) Pharma Industry Analysis
UpdatedNov 28, 2022
DataAggregated Company Financials
Companies4
- 7D1.2%
- 3M3.5%
- 1Y32.2%
- YTD29.2%
Over the last 7 days, the Pharma industry has risen 1.2%, driven by gains from every company within the industry. In the last 12 months, the industry was up 32%.
Industry Valuation and Performance
Has the Palestinian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 29 Nov 2022 | ₪266.2m | ₪135.0m | ₪24.4m | 9x | 10.9x | 2x |
| Thu, 27 Oct 2022 | ₪259.4m | ₪136.2m | ₪26.0m | 9.4x | 10x | 1.9x |
| Sat, 24 Sep 2022 | ₪260.1m | ₪136.2m | ₪26.0m | 9.4x | 10x | 1.9x |
| Mon, 22 Aug 2022 | ₪260.1m | ₪132.2m | ₪24.6m | 10.8x | 10.6x | 2x |
| Wed, 20 Jul 2022 | ₪256.0m | ₪134.4m | ₪27.2m | 9.3x | 9.4x | 1.9x |
| Fri, 17 Jun 2022 | ₪261.2m | ₪134.4m | ₪27.2m | 9.6x | 9.6x | 1.9x |
| Sun, 15 May 2022 | ₪253.0m | ₪128.6m | ₪24.5m | 10.4x | 10.3x | 2x |
| Tue, 12 Apr 2022 | ₪236.2m | ₪123.7m | ₪22.2m | 12.2x | 10.6x | 1.9x |
| Thu, 10 Mar 2022 | ₪231.2m | ₪123.7m | ₪22.2m | 11.9x | 10.4x | 1.9x |
| Sat, 05 Feb 2022 | ₪205.7m | ₪120.9m | ₪20.4m | 10.9x | 10.1x | 1.7x |
| Mon, 03 Jan 2022 | ₪207.7m | ₪120.9m | ₪20.4m | 11.1x | 10.2x | 1.7x |
| Wed, 01 Dec 2021 | ₪207.2m | ₪111.1m | ₪16.6m | 17.8x | 12.5x | 1.9x |
| Fri, 29 Oct 2021 | ₪203.9m | ₪106.3m | ₪15.2m | 18.5x | 13.4x | 1.9x |
| Sun, 26 Sep 2021 | ₪206.5m | ₪106.3m | ₪15.2m | 19x | 13.6x | 1.9x |
| Tue, 24 Aug 2021 | ₪197.0m | ₪106.3m | ₪15.2m | 17.9x | 13x | 1.9x |
| Wed, 30 Jun 2021 | ₪194.2m | ₪106.3m | ₪15.2m | 17.1x | 12.8x | 1.8x |
| Sat, 03 Apr 2021 | ₪206.0m | ₪99.1m | ₪12.6m | 20.5x | 16.4x | 2.1x |
| Tue, 05 Jan 2021 | ₪200.4m | ₪98.3m | ₪13.0m | 18.9x | 15.4x | 2x |
| Fri, 09 Oct 2020 | ₪191.8m | ₪98.1m | ₪15.2m | 14.7x | 12.6x | 2x |
| Thu, 02 Jul 2020 | ₪188.0m | ₪96.4m | ₪15.6m | 12.1x | 12.1x | 2x |
| Sun, 05 Apr 2020 | ₪191.1m | ₪96.9m | ₪17.4m | 11.8x | 11x | 2x |
| Wed, 08 Jan 2020 | ₪198.6m | ₪94.8m | ₪17.9m | 11.5x | 11.1x | 2.1x |
Price to Earnings Ratio
12.8x
Current Industry PE
- Investors are relatively neutral on the Palestinian Territory, Occupied Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 12.1x.
- The industry is trading close to its 3-year average PS ratio of 1.9x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 16% per year over the last three years.
- Revenues for these companies have grown 14% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Palestinian Pharma compare with similar industries?
| PS Market | -0.17% | |
| Healthcare | 1.11% | |
| Pharma | 1.16% | |
| Pharma | 1.16% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BPC Birzeit Pharmaceuticals | US$3.97 | 0.5% +US$775.3k | 41.8% | PE15.8x | |
| JPH Jerusalem Pharmaceuticals | US$3.54 | 1.1% +US$720.0k | 25.1% | PE8.2x | |
| BJP Beit Jala Pharmaceutical | د.أ2.85 | 1.8% +د.أ350.0k | 3.3% | PE9.7x |